pSivida Corp. Company Profile (NASDAQ:PSDV)

About pSivida Corp. (NASDAQ:PSDV)

pSivida Corp. logopSivida Corp. develops drug delivery products primarily for the treatment of chronic eye diseases. The Company operates through the biotechnology sector segment. The Company has developed three products for treatment of back-of-the-eye diseases, which include Medidur for posterior segment uveitis, its lead product candidate that is in pivotal Phase III clinical trials; ILUVIEN for diabetic macular edema (DME), its lead licensed product that is sold in the United States and European Union (EU) countries, and Retisert. Medidur is designed to treat chronic non-infectious uveitis affecting the posterior segment of the eye (posterior segment uveitis). ILUVIEN is an injectable micro-insert that provides treatment of DME from a single injection. Retisert is an implant that provides treatment of posterior segment uveitis. Its product development program is focused on utilizing its two technology platforms, Durasert and Tethadur, to deliver drugs and biologics to treat chronic diseases.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Bio Therapeutic Drugs
  • Sub-Industry: N/A
  • Symbol: NASDAQ:PSDV
  • CUSIP: N/A
  • Web: www.psivida.com/
Capitalization:
  • Market Cap: $47.25 million
  • Outstanding Shares: 39,372,000
Average Prices:
  • 50 Day Moving Avg: $1.24
  • 200 Day Moving Avg: $1.55
  • 52 Week Range: $1.03 - $2.45
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -2.14
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: $7.54 million
  • Price / Sales: 6.27
  • Book Value: $0.34 per share
  • Price / Book: 3.53
Profitability:
  • EBITDA: ($15,700,000.00)
  • Net Margins: -872.47%
  • Return on Equity: -189.83%
  • Return on Assets: -135.60%
Debt:
  • Current Ratio: 3.35%
  • Quick Ratio: 3.35%
Misc:
  • Average Volume: 505,388 shs.
  • Beta: 1.37
  • Short Ratio: 1.68
 

Frequently Asked Questions for pSivida Corp. (NASDAQ:PSDV)

What is pSivida Corp.'s stock symbol?

pSivida Corp. trades on the NASDAQ under the ticker symbol "PSDV."

How were pSivida Corp.'s earnings last quarter?

pSivida Corp. (NASDAQ:PSDV) announced its quarterly earnings results on Monday, September, 11th. The company reported ($0.16) EPS for the quarter, hitting the Thomson Reuters' consensus estimate of ($0.16). The firm had revenue of $0.70 million for the quarter, compared to analyst estimates of $0.48 million. pSivida Corp. had a negative net margin of 872.47% and a negative return on equity of 189.83%. View pSivida Corp.'s Earnings History.

When will pSivida Corp. make its next earnings announcement?

pSivida Corp. is scheduled to release their next quarterly earnings announcement on Tuesday, November, 7th 2017. View Earnings Estimates for pSivida Corp..

Where is pSivida Corp.'s stock going? Where will pSivida Corp.'s stock price be in 2017?

5 equities research analysts have issued 1-year target prices for pSivida Corp.'s shares. Their predictions range from $5.00 to $13.00. On average, they anticipate pSivida Corp.'s share price to reach $8.60 in the next year. View Analyst Ratings for pSivida Corp..

Who are some of pSivida Corp.'s key competitors?

Who are pSivida Corp.'s key executives?

pSivida Corp.'s management team includes the folowing people:

  • David J. Mazzo Ph.D., Independent Chairman of the Board
  • Nancy S. Lurker, President, Chief Executive Officer, Independent Director
  • Leonard S. Ross, Vice President - Finance, Principal Financial Officer
  • Debora A. Jorn, Executive Vice President - Corporate and Commercial Development
  • James J. Barry Ph.D., Independent Director
  • Jay S. Duker M.D., Independent Director
  • Douglas Evan Godshall M.B.A., Independent Director
  • Kristine Peterson, Independent Director
  • Michael W. Rogers, Independent Director

How do I buy pSivida Corp. stock?

Shares of pSivida Corp. can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is pSivida Corp.'s stock price today?

One share of pSivida Corp. stock can currently be purchased for approximately $1.20.


MarketBeat Community Rating for pSivida Corp. (NASDAQ PSDV)
Community Ranking:  3.3 out of 5 (star star star)
Outperform Votes:  113 (Vote Outperform)
Underperform Votes:  57 (Vote Underperform)
Total Votes:  170
MarketBeat's community ratings are surveys of what our community members think about pSivida Corp. and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for pSivida Corp. (NASDAQ:PSDV) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 5 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $8.60 (616.67% upside)
Consensus Price Target History for pSivida Corp. (NASDAQ:PSDV)
Price Target History for pSivida Corp. (NASDAQ:PSDV)
Analysts' Ratings History for pSivida Corp. (NASDAQ:PSDV)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
10/11/2017HC WainwrightSet Price TargetBuy$5.00N/AView Rating Details
6/14/2017Ladenburg Thalmann Financial ServicesSet Price TargetBuy$13.00MediumView Rating Details
6/14/2017Northland SecuritiesSet Price TargetBuy$10.00MediumView Rating Details
6/14/2017FBR & CoReiterated RatingBuyHighView Rating Details
5/30/2017Rodman & RenshawInitiated CoverageBuy$8.00HighView Rating Details
(Data available from 10/24/2015 forward)

Earnings

Earnings History for pSivida Corp. (NASDAQ:PSDV)
Earnings by Quarter for pSivida Corp. (NASDAQ:PSDV)
Earnings History by Quarter for pSivida Corp. (NASDAQ PSDV)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/7/2017($0.15)N/AView Earnings Details
9/11/2017Q4 2017($0.16)($0.16)$0.48 million$0.70 millionViewN/AView Earnings Details
5/4/2017Q3 2017($0.15)($0.15)$0.36 million$0.59 millionViewListenView Earnings Details
11/7/2016Q1($0.19)($0.21)$0.30 million$0.28 millionViewListenView Earnings Details
9/12/2016Q4($0.13)($0.19)$2.40 million$0.30 millionViewListenView Earnings Details
5/5/2016Q3($0.20)($0.15)$1.75 million$0.32 millionViewN/AView Earnings Details
11/5/2015Q116($0.15)($0.17)$0.50 million$0.47 millionViewN/AView Earnings Details
9/9/2015Q415($0.14)($0.17)$0.60 million$0.41 millionViewN/AView Earnings Details
5/8/2015Q315($0.13)($0.17)$0.33 millionViewN/AView Earnings Details
2/5/2015($0.13)($0.14)$0.52 millionViewN/AView Earnings Details
11/7/2014Q3 14($0.12)$0.67$25.30 millionViewN/AView Earnings Details
9/9/2014Q414($0.15)($0.15)$0.29 millionViewN/AView Earnings Details
5/13/2014Q314($0.15)($0.03)$0.55 million$2.00 millionViewN/AView Earnings Details
2/7/2014Q214($0.13)($0.13)$430.00 million$0.59 millionViewN/AView Earnings Details
11/12/2013Q1($0.14)ViewListenView Earnings Details
9/25/2013Q413($0.12)($0.17)$0.65 million$0.49 millionViewN/AView Earnings Details
2/6/2013Q2 2013($0.11)$0.63 million$0.59 millionViewListenView Earnings Details
11/8/2012Q113($0.10)($0.11)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for pSivida Corp. (NASDAQ:PSDV)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20171($0.19)($0.19)($0.19)
Q3 20171($0.17)($0.17)($0.17)
Q4 20171($0.12)($0.12)($0.12)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for pSivida Corp. (NASDAQ:PSDV)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for pSivida Corp. (NASDAQ:PSDV)
Insider Ownership Percentage: 2.59%
Institutional Ownership Percentage: 14.94%
Insider Trades by Quarter for pSivida Corp. (NASDAQ:PSDV)
Institutional Ownership by Quarter for pSivida Corp. (NASDAQ:PSDV)
Insider Trades by Quarter for pSivida Corp. (NASDAQ:PSDV)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/14/2017Nancy LurkerInsiderBuy56,700$1.76$99,792.00View SEC Filing  
1/4/2016Leonard S. RossVPSell5,000$4.70$23,500.00View SEC Filing  
12/22/2015Leonard S. RossVPSell33,950$5.39$182,990.50View SEC Filing  
12/22/2015Paul AshtonCEOSell120,000$5.39$646,800.00View SEC Filing  
10/1/2014Paul AshtonCEOSell10,000$4.27$42,700.00View SEC Filing  
9/2/2014Paul AshtonCEOSell10,000$4.78$47,800.00View SEC Filing  
8/1/2014Paul AshtonCEOSell10,000$4.37$43,700.00View SEC Filing  
7/1/2014Paul AshtonCEOSell10,000$4.32$43,200.00View SEC Filing  
6/19/2014Paul AshtonCEOSell7,000$4.00$28,000.00View SEC Filing  
6/17/2014Lori FreedmanVPSell7,900$4.00$31,600.00View SEC Filing  
6/17/2014Paul AshtonCEOSell7,700$4.00$30,800.00View SEC Filing  
6/13/2014Lori FreedmanVPSell11,700$4.02$47,034.00View SEC Filing  
6/13/2014Paul AshtonCEOSell11,800$4.02$47,436.00View SEC Filing  
10/1/2012Paul HopperDirectorBuy10,000$1.68$16,800.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for pSivida Corp. (NASDAQ:PSDV)
Latest Headlines for pSivida Corp. (NASDAQ:PSDV)
Source:
Loading headlines, please wait.

Social

Chart

pSivida Corp. (PSDV) Chart for Tuesday, October, 24, 2017

This page was last updated on 10/24/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.